Trials / Conditions / Cytomegalovirus (CMV) Infection
Cytomegalovirus (CMV) Infection
6 registered clinical trials studyying Cytomegalovirus (CMV) Infection — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Renal Ex Vivo SYN002 Perfusion to Eliminate CMV Transmission NCT07488481 | University Health Network, Toronto | EARLY_Phase 1 |
| Not Yet Recruiting | ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAse NCT07379203 | Wits Health Consortium (Pty) Ltd | Phase 2 |
| Enrolling By Invitation | CytoGam for CMV Infection or Disease in Solid Organ Transplant Recipients NCT07009548 | Fernanda P Silveira, MD, MS | Phase 4 |
| Completed | Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation ( NCT03940586 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients NCT03629080 | Hookipa Biotech GmbH | Phase 2 |
| Completed | In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir NCT01651585 | Assistance Publique - Hôpitaux de Paris | Phase 4 |